RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $33,000 | -42.1% | 20,959 | -21.7% | 0.00% | – |
| Q4 2019 | $57,000 | -95.4% | 26,762 | -94.4% | 0.00% | -100.0% |
| Q1 2019 | $1,232,000 | +11.2% | 479,273 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $1,108,000 | -30.8% | 481,777 | -3.4% | 0.00% | 0.0% |
| Q3 2018 | $1,602,000 | +24.1% | 498,953 | +9.4% | 0.00% | 0.0% |
| Q2 2018 | $1,291,000 | -20.5% | 456,024 | -0.6% | 0.00% | -50.0% |
| Q1 2018 | $1,623,000 | +2286.8% | 458,597 | +2313.7% | 0.00% | – |
| Q1 2015 | $68,000 | 0.0% | 19,000 | -45.7% | 0.00% | – |
| Q3 2014 | $68,000 | -46.5% | 35,000 | 0.0% | 0.00% | – |
| Q2 2014 | $127,000 | -6.6% | 35,000 | 0.0% | 0.00% | – |
| Q1 2014 | $136,000 | +40.2% | 35,000 | +29.6% | 0.00% | – |
| Q3 2013 | $97,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,020,719 | $3,746,000 | 2.58% |
| Boxer Capital, LLC | 1,351,137 | $4,959,000 | 2.22% |
| Palo Alto Investors LP | 5,186,088 | $19,033,000 | 1.11% |
| DAFNA Capital Management LLC | 340,000 | $1,248,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 907,203 | $3,329,435,000 | 0.86% |
| Rhenman & Partners Asset Management AB | 1,400,000 | $5,138,000,000 | 0.82% |
| NEA Management Company, LLC | 3,243,150 | $11,902,000 | 0.53% |
| Cormorant Asset Management, LP | 1,155,600 | $4,241,000 | 0.47% |
| Ghost Tree Capital, LLC | 700,000 | $2,569,000 | 0.42% |
| Rock Springs Capital Management LP | 1,810,000 | $6,643,000 | 0.42% |